• Health & Medicine

Prostate MRI scans could help some men avoid invasive biopsy

More than a quarter of men with suspected prostate cancer could avoid invasive biopsies if they’re offered an MRI scan first, a new study suggests. More than a quarter of men with suspected prostate cancer could avoid invasive biopsies if they’re offered an MRI scan first, a new study suggests.

21 March 2018

• Health & Medicine

Obesity risk doubles for teens bombarded with junk food adverts

Teenagers are more than twice as likely to be obese if they remember seeing a junk food advert every day compared to those who couldn’t recall any in a month. Teenagers are more than twice as likely to be obese if they remember seeing a junk food advert every day compared to those who couldn’t recall any in a month.

15 March 2018

• Health & Medicine

Binge watching TV could increase bowel cancer risk in men

Sitting down to watch more than four hours of TV over a day could increase the risk of bowel cancer in men compared to those watching less than just an hour. Sitting down to watch more than four hours of TV over a day could increase the risk of bowel cancer in men compared to those watching less than just an hour.

9 March 2018

• Health & Medicine

Choice of lung cancer treatment could be affecting survival

Variations in lung cancer treatment may be limiting survival in England, according to a new study. Variations in lung cancer treatment may be limiting survival in England, according to a new study.

8 March 2018

• Health & Medicine

Why a one-off PSA test for prostate cancer is doing men more harm than good

Our new research shows that a one-off PSA test doesn't save lives from prostate cancer. Our new research shows that a one-off PSA test doesn't save lives from prostate cancer.

6 March 2018

• Health & Medicine

One-off PSA screening for prostate cancer does not save lives

Inviting men with no symptoms to a one-off PSA test for prostate cancer does not save lives according to results from the largest ever prostate cancer trial. Inviting men with no symptoms to a one-off PSA test for prostate cancer does not save lives according to results from the largest ever prostate cancer trial.

6 March 2018

• Science & Technology

Aggressive brain tumours carry potential target for engineered immune cells

A molecule on glioblastoma cells that could be used as a target for genetically engineered immune cells has been identified. A molecule on glioblastoma cells that could be used as a target for genetically engineered immune cells has been identified.

1 March 2018

• Health & Medicine

Millennials top obesity chart before reaching middle age

More than seven in 10 millennials – those born between the early 80s and mid 90s – are set to be overweight or obese between the ages of 35-44. More than seven in 10 millennials – those born between the early 80s and mid 90s – are set to be overweight or obese between the ages of 35-44.

26 February 2018

• Health & Medicine

Three thyroid cancer drugs approved for NHS in England

Three thyroid cancer treatments have been approved for routine use on the NHS in England. Three thyroid cancer treatments have been approved for routine use on the NHS in England.

23 February 2018

• Health & Medicine

Lab-grown ‘mini tumours’ could personalise cancer treatment

Testing cancer drugs on miniature replicas of a patient’s tumour could help doctors tailor treatment, according to new research. Testing cancer drugs on miniature replicas of a patient’s tumour could help doctors tailor treatment, according to new research.

22 February 2018

• For Supporters

Patients to benefit from new brain cancer research funding boost

Brain tumour research in the UK is set to be revolutionised with £45 million in funding by the Department of Health and Social Care and Cancer Research UK. Brain tumour research in the UK is set to be revolutionised with £45 million in funding by the Department of Health and Social Care and Cancer Research UK.

22 February 2018

• Charity News

Cancer Research UK appoints leading expert to help accelerate advancements in clinical research

Cancer Research UK announces the appointment of Dr James Larkin as a new Senior Clinical Advisor in clinical research. Cancer Research UK announces the appointment of Dr James Larkin as a new Senior Clinical Advisor in clinical research.

20 February 2018